Physician profile
Omar Wain
NPI 1548548225
$16,039.31
in general payments reported to CMS, 2019-2025
22 companies · $3,735 in 2025
The $3,735 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.01 · 2020: $23.87 · 2021: $214 · 2022: $6,948 · 2023: $3,640 · 2024: $1,467 · 2025: $3,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,029 · Food and Beverage: $2,278 · Education: $1,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,029.49 |
| Food and Beverage | $2,278.33 |
| Education | $1,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,707.86 | 2021-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| Davol INC. | $2,451.61 | 2021-2025 | Phasix Mesh |
| Tela Bio, INC. | $1,419.89 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $644.21 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Octapharma USA, INC. | $124.97 | 2025 | Balfaxar |
| Medtronic, INC. | $89.33 | 2023 | Signia |
| Bioventus LLC | $71.95 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Ethicon US, LLC | $71.67 | 2025 | Dermabond, Stratafix |
| W. L. Gore & Associates, INC. | $69.89 | 2021-2025 | Gore Enform Preperitoneal Biomaterial |
| Innocoll Pharmaceuticals Limited | $68.03 | 2022 | |
| Teleflex LLC | $60.24 | 2024-2025 | Deknatel |
| Zimvie INC. | $55.20 | 2023 | |
| Chiesi USA, INC. | $28.73 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.76 | 2025 | |
| Misonix INC | $23.52 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $23.36 | 2025 | Celleraterx |
| Boston Scientific Corporation | $22.93 | 2021 | |
| Distalmotion US | $21.71 | 2025 | Dexter L6 Robot |
| Heron Therapeutics, INC. | $20.32 | 2022 | |
| Abbvie INC. | $14.84 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $14.28 | 2023 | Caldolor |
| Acell, INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Wain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.